Dr. Sally Arai, MD

Dr. Arai practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Arai's NPI, 1881739530, was assigned on February 20, 2007. Dr. Arai graduated from Geisel School Of Medicine At Dartmouth in 1991. Dr. Arai's California license number on file is G87299.

Dr. Arai's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Arai's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Arai is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Arai to 1 more hospital and 1 medical group, each named with a free account. Dr. Arai's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arai practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Arai's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Arai is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Arai's licenses on file in 4 states: California, Illinois, Maryland and New York.

Dmand AI lists lymphoma and multiple myeloma among the conditions Dr. Arai treats.

CMS data shows 339 Medicare services from Dr. Arai across 3 procedure codes in 2024, for 73 Medicare patients. Medicare paid $27,374 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Dr. Arai in 2024. The largest group is 65 to 74, with 47 patients. 70% of them have high cholesterol, and 62% have high blood pressure. 32% are also on Medicaid. Their average risk score is 3.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Arai's median patient age at 61, with 43% women.

In 2024, Dr. Arai wrote 532 Medicare Part D claims for 53 patients. 79% of them were for generic drugs. CMS names the drug for 353 of them, across 12 drugs with 11 or more claims each, at $1,338,264 in total drug cost. In 2023, CMS named 278 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Arai for performance year 2024, reported as part of a group. Dr. Arai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Arai as offering telehealth.

Dmand AI links 130 papers to Dr. Arai, published from 2002 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Transplantation Conditioning. Dr. Arai has published most often in Blood. Dr. Arai's most frequent co-authors are David Bernard Miklos, MD, PhD, Robert Lowsky, MD and Robert Stuart Negrin, MD.

Dmand AI links Dr. Arai to 17 clinical trials, 11 of them phase 2 studies. Conditions studied include Graft vs Host Disease, Multiple Myeloma and Blood Protein Disorders. Stanford University sponsors the most, 9.

CMS Open Payments shows 23 general payments to Dr. Arai from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. Sanofi and Genzyme US Companies paid the most, $3,776.

Dmand AI lists 1 award for Dr. Arai, most recently CMS Stage 1 EHR in 2012.

Dr. Arai graduated from Geisel School Of Medicine At Dartmouth in 1991. Dr. Arai is a member of ASCO.

Dr. Arai is in network with 8 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.